The management of chronic prostatitis in men with HIV

Vincent M. Santillo, Franklin C. Lowe

Research output: Contribution to journalArticle

Abstract

Prostatitis is a common urologic diagnosis. Although treatment algorithms are available for this poorly understood entity, several adaptations must be made in order to accommodate the therapeutic needs of HIV-positive patients. The most important consideration when treating HIV-infected patients for prostatitis is their current immune status, whether they are immunocompromised or not (non-progressive disease or reconstituted with highly active antiretroviral therapy). A treatment algorithm for those with chronic bacterial prostatitis (Category II), chronic nonbacterial prostatitis (Category MIA), and prostatodynia (Category IIIB) is presented in this article. In the HIV-positive patient population, there is a greater likelihood for atypical pathogens including fungi, tuberculosis, anaerobes, and viruses. Because the HIV-infected patient is at increased risk for the development of prostatic abscess and urosepsis than the general population, increased monitoring and evaluation and longer-term appropriately directed antimicrobial therapy are required.

Original languageEnglish (US)
Pages (from-to)93-99
Number of pages7
JournalCurrent Prostate Reports
Volume4
Issue number2
DOIs
Publication statusPublished - May 1 2006
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Urology

Cite this